The analysis of the tumor section measurement (Figure 4C) confirmed that depletion of CD11b+Ly6G−Ly6C− MDCs enhanced the cytotoxicity of GCV against ALTS1C1-tk tumors, as shown by the smaller tumor size on day 16 (Figure 4D). This evidence concerns the gene ITGAM and neoplasm.